Simvastatin, >=97% (HPLC), solid

Code: S6196-5MG D2-231

Application

Simvastatin has been used:as an inhibitor of HMG CoA reductase (HMGCR)to study its effects on epithelial to mesenchymal transition (EMT) and the prognosis of pati...


read more

Your Price
€65.50 5MG
€80.57 inc. VAT

Application

Simvastatin has been used:as an inhibitor of HMG CoA reductase (HMGCR)to study its effects on epithelial to mesenchymal transition (EMT) and the prognosis of patients with lung adenocarcinomain in vivostudies to test its effect on brain tumor−initiating cells (BTIC) viability and cell proliferationto study the role of adenosine triphosphate (ATP)-binding cassette transporter A7 in phagocytosis of Jurkat cellsto study the effect on endothelial dysfunction and inflammation in mice

Biochem/physiol Actions

Simvastatin is a specific inhibitor of HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, an early step in cholesterol biosynthesis. It is used in the treatment of hypercholesterolemia, as it reduces levels of low-density lipoproteins cholesterol and triglycerides, and raises high-density lipoprotein levels. Simvastatin is a lactone that is readily hydrolyzed in vivo to the corresponding β-hydroxyacid and can be activated prior to use with NaOH in EtOH treatment. It may also have beneficial effects on endothelial function, inflammation, smooth muscle cell function, vascular wall function, hemostasis and LDL oxidation.

Simvastatin is a specific inhibitor of HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, an early step in cholesterol biosynthesis. It is used in the treatment of hypercholesterolemia, as it reduces levels of low-density lipoproteins and triglycerides, and raises high-density lipoprotein levels. Simvastatin is a lactone that is readily hydrolyzed in vivo to the corresponding β-hydroxyacid, and can be activated prior to use with NaOH in EtOH treatment. It is a synthetic analog of lovastatin (Cat. No. M2147).

Features and Benefits

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

General description

Simvastatin is a prodrug. Simvastatin is a semisynthetic derivative/analog of lovastatin. Simvastatin is insoluble in water but is soluble in polar organic solvents.

Packaging

5 mg in glass bottle

25 mg in poly bottle

assay≥97% (HPLC)
colorwhite
formsolid
Gene Informationhuman ... HMGCR(3156)rat ... Hmgcr(25675)
InChI keyRYMZZMVNJRMUDD-HGQWONQESA-N
InChI1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
mp127-132 °C (lit.)
originatorMerck & Co., Inc., Kenilworth, NJ, U.S.
Quality Level100
SMILES string[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]3C[C@@H](O)CC(=O)O3)OC(=O)C(C)(C)CC
solubilityDMSO: ≥20 mg/mL
storage temp.2-8°C
Cas Number79902-63-9
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.